https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png00stephanieforsthttps://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.pngstephanieforst2022-01-11 17:27:052022-01-11 17:27:05Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry
https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png00stephanieforsthttps://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.pngstephanieforst2022-01-11 17:26:402022-01-11 17:26:40Examining the survival benefit of radiation therapy on leptomeningeal carcinomatosis and identifying factors associated with survival benefit of whole-brain radiation therapy
https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png00stephanieforsthttps://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.pngstephanieforst2022-01-11 17:26:082022-01-11 17:26:08Efficacy of Liposomal Cytarabine in the Treatment of Leptomeningeal Metastasis of Breast Cancer
https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png00stephanieforsthttps://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.pngstephanieforst2022-01-11 16:53:292022-01-11 17:14:35Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group
https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png00stephanieforsthttps://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.pngstephanieforst2022-01-11 16:49:462022-01-11 17:15:11Characteristics and outcomes of breast cancer patients with leptomeningeal metastasis
